136 related articles for article (PubMed ID: 309294)
1. The PiMZ phenotype: is it a significant risk factor for the development of chronic obstructive lung disease?
Mittman C
Am Rev Respir Dis; 1978 Oct; 118(4):649-52. PubMed ID: 309294
[No Abstract] [Full Text] [Related]
2. Alpha 1 -antitrypsin deficiency as an indicator of susceptibility to pulmonary disease.
Mittman C; Barbela T; Lieberman J
J Occup Med; 1973 Jan; 15(1):33-8. PubMed ID: 4684725
[No Abstract] [Full Text] [Related]
3. [Alpha 1-antitrypsin deficiency and chronic obstructive bronchopneumopathies].
Dyan A; Bignon J
Rev Fr Transfus Immunohematol; 1977 Mar; 20(1):89-93. PubMed ID: 302020
[No Abstract] [Full Text] [Related]
4. Host factors in bronchitis and emphysema.
Miller RD
Mayo Clin Proc; 1981 Jul; 56(7):460. PubMed ID: 6973049
[No Abstract] [Full Text] [Related]
5. Antitrypsin deficiency and abnormal protease inhibitor phenotypes.
Mittman C; Barbela T; Lieberman J
Arch Environ Health; 1973 Sep; 27(3):201-6. PubMed ID: 4198687
[No Abstract] [Full Text] [Related]
6. [The variability of clinical presentation of chronic obstructive pulmonary disease in patients with hereditary alpha-1 antitrypsin deficiency].
Kuca P; Kamiński D; Campbell E; Kołakowski J; Goljan-Geremek A; Puścińska E; Bieleń P; Nowiński A; Wojda E; Hawryłkiewicz I; Sliwiński P; Górecka D
Pneumonol Alergol Pol; 2004; 72(9-10):420-3. PubMed ID: 16021998
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of abnormal protease inhibitor phenotypes in patients with chronic obstructive lung disease.
Mittman C; Lieberman J; Rumsfeld J
Am Rev Respir Dis; 1974 Feb; 109(2):295-6. PubMed ID: 4811786
[No Abstract] [Full Text] [Related]
8. [Genetically-induced deficiency of alpha 1-antitrypsin and diseases of the lung--current assessment and perspectives].
Stobernack A; Theise H; Tischer H; Correns A
Z Arztl Fortbild (Jena); 1990; 84(22):1144-8. PubMed ID: 2087809
[No Abstract] [Full Text] [Related]
9. Genetic epidemiology of severe, early-onset chronic obstructive pulmonary disease. Risk to relatives for airflow obstruction and chronic bronchitis.
Silverman EK; Chapman HA; Drazen JM; Weiss ST; Rosner B; Campbell EJ; O'DONNELL WJ; Reilly JJ; Ginns L; Mentzer S; Wain J; Speizer FE
Am J Respir Crit Care Med; 1998 Jun; 157(6 Pt 1):1770-8. PubMed ID: 9620904
[TBL] [Abstract][Full Text] [Related]
10. Protease inhibitors in chronic obstructive pulmonary disease.
Barnett TB; Gottovi D; Johnson AM
Am Rev Respir Dis; 1975 May; 111(5):587-93. PubMed ID: 1079422
[TBL] [Abstract][Full Text] [Related]
11. Alpha1-antitrypsin deficiency (second of two parts).
Morse JO
N Engl J Med; 1978 Nov; 299(20):1099-105. PubMed ID: 360065
[No Abstract] [Full Text] [Related]
12. Effects of smoking and intermediate alpha 1-antitrypsin deficiency (PiMZ) on lung function.
Eriksson S; Lindell SE; Wiberg R
Eur J Respir Dis; 1985 Oct; 67(4):279-85. PubMed ID: 3878302
[TBL] [Abstract][Full Text] [Related]
13. [Alpha 1-antiproteinase deficiency].
Ritscher D; Russi EW
Ther Umsch; 1999 Mar; 56(3):142-6. PubMed ID: 10218436
[TBL] [Abstract][Full Text] [Related]
14. Risk of hospital admission for obstructive pulmonary disease in alpha(1)-antitrypsin heterozygotes of phenotype PiMZ.
Seersholm N; Wilcke JT; Kok-Jensen A; Dirksen A
Am J Respir Crit Care Med; 2000 Jan; 161(1):81-4. PubMed ID: 10619801
[TBL] [Abstract][Full Text] [Related]
15. Assessment of alpha-1-antitrypsin deficiency heterozygosity as a risk factor in the etiology of emphysema. Physiological comparison of adult normal and heterozygous protease inhibitor phenotype subjects from a random population.
McDonagh DJ; Nathan SP; Knudson RJ; Lebowitz MD
J Clin Invest; 1979 Feb; 63(2):299-309. PubMed ID: 311786
[TBL] [Abstract][Full Text] [Related]
16. [Laboratory procedures in the detection of deficiencies and the determination of alpha 1-antitrypsin phenotypes in the blood serum].
Piłacik B; Kowalczyk J
Med Pr; 1979; 30(3):207-12. PubMed ID: 314559
[TBL] [Abstract][Full Text] [Related]
17. Proteases and protease inhibitors in chronic obstructive lung disease.
Erikson S
Acta Med Scand; 1978; 203(6):449-55. PubMed ID: 78661
[No Abstract] [Full Text] [Related]
18. Chronic obstructive pulmonary disease and alpha-1-antitrypsin (Pi) variation: a family study.
Benjamin JJ; Cohen BH; Ball WC; Levy DA; Menkes HA; Kreiss P
Birth Defects Orig Artic Ser; 1974; 10(4):212-6. PubMed ID: 4549777
[TBL] [Abstract][Full Text] [Related]
19. A study on the lung function in alpha 1-antitrypsin-deficient (PiMZ) patients.
Kambe M; Morishita K; Tsubokura T; Tsuno K; Kimura T; Utsumi T; Kawamoto H; Yamakido M; Mittman C
Hiroshima J Med Sci; 1993 Mar; 42(1):41-5. PubMed ID: 8486520
[TBL] [Abstract][Full Text] [Related]
20. Antitrypsin deficiency: a model to illustrate the pathogenesis of emphysema.
Mittman C
Nihon Kyobu Shikkan Gakkai Zasshi; 1978 Jun; 16(6):369-82. PubMed ID: 309017
[No Abstract] [Full Text] [Related]
[Next] [New Search]
